WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018051291) VACCINE COMPOSITION FOR PROTECTION AGAINST TEGUMENTARY LEISHMANIASIS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/051291    International Application No.:    PCT/IB2017/055614
Publication Date: 22.03.2018 International Filing Date: 15.09.2017
IPC:
A61K 39/008 (2006.01), C07K 9/00 (2006.01), A61P 33/02 (2006.01)
Applicants: UNIVERSIDADE FEDERAL DE MINAS GERAIS [BR/BR]; Av. Antônio Carlos, 6627 - Unidade Administrativa II - 2º andar- sala 2011 31270-901 Belo Horizonte (BR).
UNIVERSIDADE FEDERAL DE UBERLÂNDIA - UFU [BR/BR]; AVENIDA JOÃO NAVES DE ÁVILA, 2121, CX593, CAMPUS SANTA MÔNICA. 38408100 UBERLÂNDIA (BR)
Inventors: FERRAZ COELHO, Eduardo Antônio; (BR).
PEREIRA TAVARES, Carlos Alberto; (BR).
COSTA, Lourena Emanuele; (BR).
TEIXEIRA JÚNIOR, Antônio Lúcio; (BR).
SILVEIRA SALLES, Beatriz Cristina; (BR).
UTSCH GONÇALVES, Denise; (BR).
MENEZES SOUZA, Daniel; (BR).
COSTA DUARTE, Mariana; (BR).
MENDES ROATT, Bruno; (BR).
GOULART FILHO, Luiz Ricardo; (BR)
Priority Data:
BR 10 2016 021357 6 16.09.2016 BR
Title (EN) VACCINE COMPOSITION FOR PROTECTION AGAINST TEGUMENTARY LEISHMANIASIS
(FR) COMPOSITION VACCINALE POUR PROTECTION CONTRE LA LEISHMANIOSE TÉGUMENTAIRE
(PT) COMPOSIÇÃO VACINAL PARA PROTEÇÃO CONTRA A LEISHMANIOSE TEGUMENTAR
Abstract: front page image
(EN)The present technology relates to vaccine compositions comprising at least one of the nine peptides defined by SEQ ID NO 1-9, capable of stimulating the development of a T helper 1 (Th1)-type cell immune response with high production of interferon-gamma (IFN- ) and low levels of interleukin-4 (IL-4) for preventing tegumentary leishmaniasis in mammals.
(FR)La présente technologie concerne des compositions vaccinales comprenant au moins l'un des neuf peptides définis par les SEQ ID No 1 à 9, permettant de stimuler le développement d'une réponse immunitaire cellulaire du type T helper 1 (Th1) avec une production élevée d'interféron gamma (IFN-gamma) et de faibles taux d'interleukine 4 (IL-4), pour la prévention de la leishmaniose tégumentaire chez des mammifères.
(PT)1/1 RESUMO PROTEÇÃO CONTRA A A presente tecnologia trata de composições vacinais compreendendo pelo menos um dos nove peptídeos definidos pelas SEQ ID No 1 a 9, capazes de estimular o desenvolvimento de uma resposta imune celular do tipo T helper 1 (Th1) com elevada produção de Interferon-gamma (IFN- ) e baixos níveis de Interleucina-4 (IL-4), para prevenção da leishmaniose tegumentar em mamíferos.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Portuguese (PT)
Filing Language: Portuguese (PT)